Evidence map›Paper›PMID 35038835›Full record

ArticleAnnals of pediatric endocrinology & metabolism2022

Response to growth hormone according to provocation test results in idiopathic short stature and idiopathic growth hormone deficiency.

Ju Young Yoon, Chong Kun Cheon, Jung Hyun Lee, Min Jung Kwak, Hyun-Ji Kim, Ye Jin Kim, Jeong Eun Lee, Woo Yeong Chung, Jeongyun Kim, Jae-Ho Yoo

Open access · diamondAbstract read
In one paragraph

Article in Annals of pediatric endocrinology & metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The effects of growth hormone treatment on height in short children.Annals of pediatric endocrinology & metabolism · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Ju Young YoonDepartment of Pediatrics, Pusan National University Children's Hospital, Yangsan, Korea.
Chong Kun CheonDepartment of Pediatrics, Pusan National University Children's Hospital, Yangsan, Korea.
Jung Hyun LeeDepartment of Pediatrics, Kosin University Gospel Hospital, Busan, Korea.
Min Jung KwakDepartment of Pediatrics, Pusan National University Hospital, Busan, Korea.
Hyun-Ji KimDepartment of Pediatrics, Ilsin Christian Hospital, Busan, Korea.
Ye Jin KimDepartment of Pediatrics, Inje University Haeundae Paik Hospital, Busan, Korea.
Jeong Eun LeeDepartment of Pediatrics, Inje University Busan Paik Hospital, Busan, Korea.
Woo Yeong ChungDepartment of Pediatrics, Inje University Busan Paik Hospital, Busan, Korea.
Jeongyun KimLG Chem, Ltd., Seoul, Korea.
Jae-Ho YooDepartment of Pediatrics, Dong-A University Hospital, Busan, Korea.
Kosin University Gospel Hospital · KRPusan National University Yangsan Hospital · KRDong-A University Hospital · KRInje University Busan Paik Hospital · KRInje University Haeundae Paik Hospital · KRLG (South Korea) · KRPusan National University Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate growth response in children with either idiopathic short stature (ISS) or growth hormone (GH) deficiency (GHD).

methodsThe data of prepubertal GHD or ISS children treated using recombinant human GH were obtained from the LG Growth Study database. GHD children were further divided into partial and complete GHD groups. Growth response and factors predicting growth response after 1 and 2 years of GH treatment were investigated.

resultsThis study included 692 children (98 with ISS, 443 partial GHD, and 151 complete GHD). After 1 year, changes in height standard deviation score (ΔHt-SDS) were 0.78, 0.83, and 0.96 in ISS, partial GHD, and complete GHD, respectively. Height velocity (HV) was 8.72, 9.04, and 9.52 cm/yr in ISS, partial GHD, and complete GHD, respectively. ΔHt-SDS and HV did not differ among the 3 groups. Higher initial body mass index standard deviation score (BMI-SDS) and midparental height standard deviation score (MPH-SDS) were predictors for better growth response after 1 year in ISS and the partial GHD group, respectively. In the complete GHD group, higher Ht-SDS and BMI-SDS predicted better growth response after 1 year. After 2 years of GH treatment, higher BMI-SDS and MPH-SDS predicted a better growth outcome in the partial GHD group, and higher MPH-SDS was a predictor of good growth response in complete GHD.

conclusionClinical characteristics and growth response did not differ among groups. Predictors of growth response differed among the 3 groups, and even in the same group, a higher GH dose would be required when poor response is predicted.

Indexed as

Growth hormoneGrowth hormone deficiencyResponse

Identifiers

PMID35038835
PMCPMC8984754
OpenAlexW4205209571

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.